These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30958863)

  • 1. Post-exposure administration of chimeric antibody protects mice against European, Siberian, and Far-Eastern subtypes of tick-borne encephalitis virus.
    Matveev AL; Kozlova IV; Stronin OV; Khlusevich YA; Doroshchenko EK; Baykov IK; Lisak OV; Emelyanova LA; Suntsova OV; Matveeva VA; Savinova JS; Tikunova NV
    PLoS One; 2019; 14(4):e0215075. PubMed ID: 30958863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of immune response and protective effect of four vaccines against the tick-borne encephalitis virus.
    Morozova OV; Bakhvalova VN; Potapova OF; Grishechkin AE; Isaeva EI; Aldarov KV; Klinov DV; Vorovich MF
    Vaccine; 2014 May; 32(25):3101-6. PubMed ID: 24631082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
    Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
    Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of neutralizing monoclonal antibody against tick-borne encephalitis virus in vivo.
    Matveev A; Matveev L; Stronin O; Baykov I; Emeljanova L; Khlusevich Y; Tikunova N
    Vaccine; 2020 Jun; 38(27):4309-4315. PubMed ID: 32409136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad and potent neutralizing human antibodies to tick-borne flaviviruses protect mice from disease.
    Agudelo M; Palus M; Keeffe JR; Bianchini F; Svoboda P; Salát J; Peace A; Gazumyan A; Cipolla M; Kapoor T; Guidetti F; Yao KH; Elsterová J; Teislerová D; Chrdle A; Hönig V; Oliveira T; West AP; Lee YE; Rice CM; MacDonald MR; Bjorkman PJ; Růžek D; Robbiani DF; Nussenzweig MC
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33831141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational and Rational Design of Single-Chain Antibody against Tick-Borne Encephalitis Virus for Modifying Its Specificity.
    Baykov IK; Desyukevich PY; Mikhaylova EE; Kurchenko OM; Tikunova NV
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
    Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
    mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tick-borne encephalitis virus vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans.
    Orlinger KK; Hofmeister Y; Fritz R; Holzer GW; Falkner FG; Unger B; Loew-Baselli A; Poellabauer EM; Ehrlich HJ; Barrett PN; Kreil TR
    J Infect Dis; 2011 Jun; 203(11):1556-64. PubMed ID: 21592984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
    Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
    J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
    Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
    Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.
    Omori-Urabe Y; Yoshii K; Ikawa-Yoshida A; Kariwa H; Takashima I
    Microbiol Immunol; 2011 Dec; 55(12):893-7. PubMed ID: 22004565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Neutralizing Epitope Exposed on the Domain II of Tick-Borne Encephalitis Virus Envelope Glycoprotein E.
    Matveev A; Khlusevich Y; Kozlova I; Matveev L; Emelyanova L; Tikunov A; Baykov I; Tikunova N
    Viruses; 2023 May; 15(6):. PubMed ID: 37376556
    [No Abstract]   [Full Text] [Related]  

  • 15. Ability of inactivated vaccines based on far-eastern tick-borne encephalitis virus strains to induce humoral immune response in originally seropositive and seronegative recipients.
    Maikova GB; Chernokhaeva LL; Rogova YV; Kozlovskaya LI; Kholodilov IS; Romanenko VV; Esyunina MS; Ankudinova AA; Kilyachina AS; Vorovitch MF; Karganova GG
    J Med Virol; 2019 Feb; 91(2):190-200. PubMed ID: 30204244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
    Chidumayo NN; Yoshii K; Kariwa H
    Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
    Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of European tick-borne encephalitis virus vaccine against recent Siberian and far-eastern subtype strains.
    Hayasaka D; Goto A; Yoshii K; Mizutani T; Kariwa H; Takashima I
    Vaccine; 2001 Sep; 19(32):4774-9. PubMed ID: 11535329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A protective chimeric antibody to tick-borne encephalitis virus.
    Baykov IK; Matveev AL; Stronin OV; Ryzhikov AB; Matveev LE; Kasakin MF; Richter VA; Tikunova NV
    Vaccine; 2014 Jun; 32(29):3589-94. PubMed ID: 24837772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.